de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Meeting Abstract

Impact of Influenza A virus hemagglutinin N-glycosylation on immunogenicity

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86452

Rödig,  J.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86442

Rapp,  E.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Hütter, J., Rödig, J., Reichl, U., Seeberger, P. H., Rapp, E., & Lepenies, B. (2011). Impact of Influenza A virus hemagglutinin N-glycosylation on immunogenicity. Glycoconjugate Journal, 28(5 - Special Issue: XXI International Symposium on Glycoconjugates), 305.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-8DC1-D
Abstract
Glycosylation of infl uenza virus proteins is host dependent and can infl uence protein properties such as structural stability, protease resistence, or biological activity. It has already been reported that hemagglutinin (HA) from the infl uenza A H1N1/PR/8/34/RKI strain propagated in various cell lines exhibits distinct N-glycosylation patterns. However, it is still discussed whether and in which way differential glycosylation effects immunogenicity of the virus. In this study, we investigated whether the difference in the N-glycosylation pattern of infl uenza A virus produced in MDCK cells (M-variant) or Vero cells (V-variant) had an impact on virus immunogenicity. For this purpose, a stimulation assay using TCR-HA transgenic spleen cells was performed. All T cells from TCR-HA transgenic mice have an αβ T cell receptor specific for the peptide 110-120 from infl uenza HA presented by I-Ed MHC class II molecules. In this assay, a signifi cant difference in the up-regulation of the T cell activation marker CD69 and in cytokine production was observed. Spleen cells incubated with the V-variant up-regulated CD69 faster and to a signifi cantly higher extent than splenocytes incubated with the M-variant. Additionally, the V-variant led to a signifi cantly increased secretion of IL-2. In contrary, spleen cells incubated with the M-variant secreted higher levels of effector cytokines such as IL-4 and IFN-γ. The difference in the immunostimulatory effect can be due to a differential uptake and/or processing of virus derived proteins or recognition by different lectin receptors leading to the activation of distinct signaling pathways. In conclusion, we show that virus protein glycosylation has a signifi cant effect on immunogenicity. This finding might have important implications for infl uenza vaccine manufacturing. In vivo immunization studies with TCR-HA transgenic mice are currently ongoing.